{
  "docId": "019de076-9434-73df-8e70-401e13bb3d65",
  "docSlug": "692690be0ea25b83b6a4c7490ff14999",
  "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides",
  "authorId": "bioatla",
  "authorName": "BioAtla",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 55,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 24,
  "notes": "Includes specific response rates, disease control rates, and confidence intervals for two patient cohorts.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/33",
  "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65",
  "deckJsonHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65.json",
  "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.11,
        "w": 0.88,
        "x": 0.11,
        "y": 0.828
      },
      "kind": "paragraph",
      "text": "Monotherapy median Duration of Response was estimated to be 4.8 months with a range of 2.3-12.1+ months. Combination therapy (n=17): Evaluable patients (majority with 4+ prior lines of therapy) received BA3011 + nivolumab. One patient experienced an ongoing complete response (CR), 2 patients experienced PR, and 8 patients experienced stable disease (SD).",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e7ebda8-83b4-4a3e-9f47-134dda1a92ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.11,
        "y": 0.948
      },
      "kind": "source-note",
      "text": "Rotow J, Dy GK, Camidge DR. Poster presented at: International Association for the Study of Lung Cancer 2023 North America Conference on Lung Cancer; December 1-3, 2023; Chicago, IL.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1812852a-5d08-4623-927e-e327dd33840c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.602,
        "w": 0.942,
        "x": 0.029,
        "y": 0.197
      },
      "kind": "table",
      "text": "Data table showing Best Overall Response, Response Rate, and Disease Control Rate for two patient cohorts.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c9ae0d1-0733-4aa9-8bc3-5bc43b13ea8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.595,
        "x": 0.038,
        "y": 0.138
      },
      "kind": "title",
      "text": "Monotherapy 1.8 mg/kg Q2W shows encouraging efficacy signals",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adec60b4-3ed8-4c2c-9869-5689192a791c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.042,
        "w": 0.625,
        "x": 0.038,
        "y": 0.075
      },
      "kind": "title",
      "text": "Phase 2 CAB-AXL (BA3011) Non-Squamous NSCLC",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0037bad4-5120-4382-8b4b-68590b6ecd7d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "03d3fa29-4d4e-430a-a13f-d7f7e059ee37",
      "evidence": "table/data: Data table showing Best Overall Response, Response Rate, and Disease Control Rate for two patient cohorts.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}